The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction.

作者信息

Scharping Nicole E, Menk Ashley V, Moreci Rebecca S, Whetstone Ryan D, Dadey Rebekah E, Watkins Simon C, Ferris Robert L, Delgoffe Greg M

出版信息

Immunity. 2016 Sep 20;45(3):701-703. doi: 10.1016/j.immuni.2016.08.009.

DOI:10.1016/j.immuni.2016.08.009

PMID:27653602

Abstract

摘要

相似文献

[1]

The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction.

Immunity. 2016-9-20

[2]

Two-compartment tumor metabolism: autophagy in the tumor microenvironment and oxidative mitochondrial metabolism (OXPHOS) in cancer cells.

Cell Cycle. 2012-7-1

[3]

4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses.

J Exp Med. 2018-3-6

[4]

Enhancement of mitochondrial biogenesis and paradoxical inhibition of lactate dehydrogenase mediated by 14-3-3η in oncocytomas.

J Pathol. 2018-5-29

[5]

Mitochondrial biogenesis drives a vicious cycle of metabolic insufficiency and mitochondrial DNA deletion mutation accumulation in aged rat skeletal muscle fibers.

PLoS One. 2013-3-13

[6]

Telomere dysfunction induces metabolic and mitochondrial compromise.

Nature. 2011-2-9

[7]

[Metabolic Competition in Tumor Microenvironment].

Gan To Kagaku Ryoho. 2017-11

[8]

Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin.

Biochem Pharmacol. 2019-12-27

[9]

Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease.

J Mol Med (Berl). 2010-8-20

[10]

Receptor-interacting Protein 140 represses Sirtuin 3 to facilitate hypertrophy, mitochondrial dysfunction and energy metabolic dysfunction in cardiomyocytes.

Acta Physiol (Oxf). 2016-10-12

引用本文的文献

[1]

T lymphocyte subsets and mitochondrial index predict outcomes in advanced non small cell lung cancer therapy.

Sci Rep. 2025-8-31

[2]

Immunometabolic Targets in CD8 T Cells within the Tumor Microenvironment of Hepatocellular Carcinoma.

Liver Cancer. 2024-11-21

[3]

Development of therapeutic cancer vaccines based on cancer immunity cycle.

Front Med. 2025-7-14

[4]

Regulatory T cells in the tumour microenvironment.

Nat Rev Cancer. 2025-6-10

[5]

Monoclonal antibody immune therapy response instrument for stratification and cost-effective personalized approaches in 3PM-guided pan cancer management.

EPMA J. 2025-3-22

[6]

Impact of mitochondrial metabolism on T-cell dysfunction in chronic lymphocytic leukemia.

Front Cell Dev Biol. 2025-4-17

[7]

Metabolic Dialogue Shapes Immune Response in the Tumor Microenvironment.

Eur J Immunol. 2025-4

[8]

Mechanisms of Resistance to Anti-PD-1 Immunotherapy in Melanoma and Strategies to Overcome It.

Biomolecules. 2025-2-12

[9]

Mitigating T-cell mitochondrial dysfunction in CLL to augment CAR T-cell therapy: evaluation in an immunocompetent model.

Blood Adv. 2025-5-27

[10]

Nutrient-driven histone code determines exhausted CD8 T cell fates.

Science. 2025-2-7

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献